Benfotiamine By XYMOGEN Overview & Drug Interactions

Check For Interactions With Benfotiamine

Supplement: Benfotiamine by XYMOGEN

Benfotiamine Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Benfotiamine by XYMOGEN

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Benfotiamine. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about Benfotiamine interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 60
UPC/BARCODE 871149003616

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Benfotiamine
300 mg
Benfotiamine --

Other Ingredients:
Microcrystalline Cellulose
Hypromellose
Water
Ascorbyl Palmitate
Silica
Medium-Chain Triglyceride Oil


Label Statments:


Suggested/Recommended/Usage/Directions
- Directions: Take two capsules in the morning and two capsules in the evening, or as directed by your healthcare professional.
Precautions
- Consult your healthcare professional prior to use.
- Individuals taking medication should discuss potential interactions with their healthcare professional.
- Do not use if tamper seal is damaged.
- Storage: Keep closed in a cool, dry place out of reach of children.
Formula
- Benfotiamine is a lipid-soluble derivative of thiamin that demonstrates improved absorption and duration of activity compared to water-soluble thiamin. Benfotiamine activates transketolase activity, thereby facilitating conversion of harmful glucose metabolites and positively affecting AGE formation. It supports peripheral nerve health and may support vascular health, including the microvasculature of the retina and kidney. Benfotiamine is also an excellent way to improve thiamin status.
- Lipid-Soluble, Highly Bioavailable Thiamin Derivative
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Storage
- Storage: Keep closed in a cool, dry place out of reach of children.
Formulation
- Formulated to exclude: Wheat, gluten, corn, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.
Seals/Symbols
- Vegetarian caps
- ePV (ePedigree Verification)
- GMP compliant third-party verified
Brand IP Statement(s)
- Copyright 2022 XYMOGEN
- XYMOGEN Exclusive Professional Formulas
FDA Statement of Identity
- Dietary Supplement
General Statements
- Scan to learn more! This package is completely recyclable

Brand Information

See all products by this brand

Manufacturer
Name XYMOGEN
Street Address 6900 Kingspointe Pkwy.
City Orlando
State FL
ZipCode 32819
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.